Skip to content

Zymeworks ZYME Operating Lease Liability Payments Due

Operating Lease Liability Payments Due at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$82.5M
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$18.96M+32.4%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$96.65M-13.8%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's operating lease liability payments due.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's operating lease liability payments due?
Zymeworks (ZYME) reported operating lease liability payments due of $19.39M in Q1 2026.
How has Zymeworks's operating lease liability payments due changed year-over-year?
Zymeworks's operating lease liability payments due decreased by 8.4% year-over-year, from $21.18M to $19.39M.
What does operating lease liability payments due mean?
This represents the total future cash outflows required to satisfy operating lease agreements. It reflects the company's reliance on leased assets rather than owned assets to conduct business operations. Monitoring this helps evaluate the company's operational leverage and fixed cost structure.